Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1800 of 2228 entries
View as:

Blood Pressure Reduction in Danish General Practice (BRIDGE)

Phase: N/A Priority: Normal
NCT ID: NCT00244660 Org: User:
Start: 11/30/05 End: 06/30/07 Due: 06/30/08

Transporter Cocktail Mutual Interaction

Phase: N/A Priority: Normal
NCT ID: NCT02854527 Org: User:
Start: 08/22/16 End: 11/19/16 Due: 11/19/17

A Long-term Study on the Side Effects of TRADIANCE in Japanese Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT03761797 Org: User:
Start: 01/15/19 End: 04/27/21 Due: 04/27/22

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00400153 Org: User:
Start: 11/30/06 End: - Due: -

A Study in Healthy Men to Test How BI 765080 is Taken up in the Body When Given as an Injection Under the Skin Compared With an Infusion Into the Vein

Phase: N/A Priority: Normal
NCT ID: NCT05075772 Org: User:
Start: 10/25/21 End: 03/11/22 Due: 03/11/23

Study to Investigate Pharmacokinetics (PK) of Pramipexole in Pediatric Patients Who Are Individually Optimized to Stable Pramipexole Doses for the Treatment of Idiopathic Restless Legs Syndrome (RLS)

Phase: N/A Priority: Normal
NCT ID: NCT02231918 Org: User:
Start: 05/31/06 End: - Due: -

Bioavailability of BI 1356 Administered With and Without Food to Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02183493 Org: User:
Start: 10/31/08 End: - Due: -

Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]

Phase: N/A Priority: Normal
NCT ID: NCT03265145 Org: User:
Start: 09/20/17 End: 09/30/20 Due: 09/30/21

LUX-Lung 4: BIBW 2992 (Afatinib) Phase I Trial in Advanced Non Small Cell Lung Cancer Patients & Phase II Trial in Non Small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib

Phase: N/A Priority: Normal
NCT ID: NCT00711594 Org: User:
Start: 04/30/08 End: 11/30/13 Due: 11/30/14

Lacidipine in Medical Practice in Patients With Mild to Moderate Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02177331 Org: User:
Start: 06/30/95 End: - Due: -

Multiple Rising Oral Doses of BI 691751 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02148107 Org: User:
Start: 05/31/14 End: 08/31/14 Due: 08/31/15

Bioavailability of Combination Tablet BI 1356/Metformin Compared With Single BI 1356 and Metformin Administered Together to Healthy Male and Female Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02173639 Org: User:
Start: 04/30/09 End: - Due: -

Study to Evaluate the Effects of Underlying Renal or Hepatic Dysfunction on the Pharmacokinetics of Nevirapine

Phase: N/A Priority: Normal
NCT ID: NCT02184091 Org: User:
Start: 01/31/99 End: - Due: -

A Dose-escalation Study of BIBF 1120 in Japanese Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02182128 Org: User:
Start: 06/30/06 End: - Due: -

Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak (PtP) N2/P2-component Amplitude of Laser (Somatosensory, Radiant-heat) Evoked Potentials (LEP) in UVB(Ultraviolet)-Irradiated Skin in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02037165 Org: User:
Start: 01/21/14 End: 04/15/14 Due: 04/15/15

ADESPI: Adherence to Spiriva® in Patients With COPD (Chronic Obstructive Pulmonary Disease), Measured by Morisky-8 (MMAS-8) Scale, in Routine Medical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01388166 Org: User:
Start: 09/30/11 End: 12/31/13 Due: 12/31/14

Spiriva® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT02172482 Org: User:
Start: 06/30/02 End: - Due: -

Clinical Characteristics and Practice Patterns of Type 2 Diabetes Mellitus Patients Treated With OADs in Japan: Analysis of Medical and Health Care Database of the MDV

Phase: N/A Priority: Normal
NCT ID: NCT03092752 Org: User:
Start: 03/01/17 End: 03/01/17 Due: 03/01/18

Evaluation of the Pharmacokinetic Interaction of Steady State Tipranavir and Ritonavir or Tipranavir and Ritonavir With Single Dose Didanosine in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02251873 Org: User:
Start: 09/30/01 End: - Due: -

Combivent® HFA-propelled Compared to CFC-propelled Metered Dose Inhaler in Patients With COPD (Chronic Obstructive Pulmonary Disease)

Phase: N/A Priority: Normal
NCT ID: NCT02182869 Org: User:
Start: 04/30/01 End: - Due: -

LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01523587 Org: User:
Start: 03/05/12 End: 12/27/17 Due: 12/27/18

A Trial Comparing Treatment With Tiotropium Inhalation Capsules to Combivent Inhalation Aerosol in COPD Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00359788 Org: User:
Start: 07/31/06 End: - Due: -

Single Rising Dose Tolerability Study of BIBN 4096 BS in Healthy Male and Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02198326 Org: User:
Start: 07/31/99 End: - Due: -

All-Case Surveillance of Prizbind®

Phase: N/A Priority: Normal
NCT ID: NCT02946931 Org: User:
Start: 11/18/16 End: 11/03/20 Due: 11/03/21

Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen

Phase: N/A Priority: Normal
NCT ID: NCT02191332 Org: User:
Start: 12/31/99 End: - Due: -